Want to see TSE:PSYC full AI Analyst Report?
PSYC Stock Chart & Stats
C$0.01
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.01
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.03
Previous CloseN/A
Volume16.00K
Average Volume (3M)81.03K
Market Cap
C$4.08M
Enterprise ValueC$3.21
Total Cash (Recent Filing)C$605.05K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.38
Next Earnings
Oct 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding407,715,850
10 Day Avg. Volume36,477
30 Day Avg. Volume81,030
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.86
Price to Sales (P/S)12.22
P/FCF Ratio-1.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
No Debt On Balance SheetZero reported debt meaningfully reduces fixed financing obligations and interest burden, giving management flexibility to prioritize operations or raise capital on better terms. This durable structural strength lowers bankruptcy risk while the company addresses cash burn and execution.
Revenue Improvement (TTM)Consistent top-line growth shows underlying product traction and market demand for Amanita muscaria offerings. While absolute sales remain small, durable revenue momentum is a prerequisite for scaling margins and justifies continued investment in distribution and product development.
Established Consumer Sales ChannelsA multi-channel consumer distribution model (DTC plus retail/wholesale) supports scalable revenue expansion, brand building, and reuse of customer data for marketing. Structural nutraceutical demand and a branded product line create repeatable routes-to-market over the medium term.
Bears Say
Negative Gross ProfitabilityA gross margin near -47% means cost of goods sold materially exceeds revenue, indicating pricing, sourcing or formulation issues. This is a fundamental profitability problem that undermines operating leverage and cannot be solved by cutting SG&A alone; it threatens long-term viable unit economics.
Heavy Persistent Cash BurnSustained negative operating and free cash flow drains liquidity and shortens runway, forcing dilution or external financing. Persistent cash burn restricts the company's ability to invest in manufacturing, regulatory work or channel expansion, impairing long-term scaling prospects.
Equity Erosion/dilutionA sharp decline in book equity reflects accumulated losses and likely dilution, reducing the balance-sheet cushion for shocks. This weakens financial flexibility, increases funding risk, and makes future capital raises more dilutive or costly, harming long-term shareholder value creation.
Psyched Wellness News
PSYC FAQ
What was Psyched Wellness’s price range in the past 12 months?
Psyched Wellness lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.
What is Psyched Wellness’s market cap?
Psyched Wellness’s market cap is C$4.08M.
When is Psyched Wellness’s upcoming earnings report date?
Psyched Wellness’s upcoming earnings report date is Oct 22, 2026 which is in 77 days.
How were Psyched Wellness’s earnings last quarter?
Psyched Wellness released its earnings results on Jul 24, 2026. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Psyched Wellness overvalued?
According to Wall Street analysts Psyched Wellness’s price is currently Overvalued.
Does Psyched Wellness pay dividends?
Psyched Wellness does not currently pay dividends.
What is Psyched Wellness’s EPS estimate?
Psyched Wellness’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psyched Wellness have?
Psyched Wellness has 407,715,850 shares outstanding.
What happened to Psyched Wellness’s price movement after its last earnings report?
Psyched Wellness reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Psyched Wellness?
Currently, no hedge funds are holding shares in TSE:PSYC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Psyched Wellness
Psyched Wellness Ltd. operates as a health supplements enterprise, specializing in the production and distribution of artisanal medicinal mushrooms and their associated consumer packaged goods. A prominent offering is their Amanita Muscaria Tincture, formulated to soothe the body, alleviate physical discomfort, reduce stress, ease muscular tension, and promote restorative sleep. The company, established in 2019, was initially known as Duncan Park Holdings Corporation before officially adopting the name Psyched Wellness Ltd. in July 2020. Its headquarters are situated in Toronto, Canada.
Technical Analysis
Blender Bites
―
Jamieson Wellness Inc
―
Happy Belly Food Group
―
Happy Supplements Inc.
―
Cult Food Science Corp.
―